Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity

Autor: Joud Arnouk, Vikrant P. Rachakonda, Diana Jaiyeola, Jaideep Behari

Publikováno v: Hepatology Communications, Vol 4, Iss 10, Pp 1419-1429 (2020)

Nonalcoholic fatty liver disease (NAFLD) is closely associated with obesity. The prevalence of extreme obesity, defined as body mass index (BMI) of 50 kg/m2 or higher, is rising more rapidly than overall obesity. We aimed to compare the clinical outc

Externí odkaz: https://doaj.org/article/4eafaf277cd44787b0ef8615ed06ac4c

S88 Immune Checkpoint-Inhibitors Are Associated With a Higher Risk of Cholangitis: A Nationwide Population-Wide Study

Autor: Ahmed Eltelbany, Khaled Alsabbagh Alchirazi, Osama Hamid, Yazan Abu Omar, Rama Nanah, Joud Arnouk, Madhusudhan Sanaka, Prashanthi Thota

Publikováno v: American Journal of Gastroenterology. 117:e66-e66

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::414b4ddecd77b98eaf3971d202988c08
https://doi.org/10.14309/01.ajg.0000856992.37501.ec

A Celiac Disease Phenotype After Checkpoint Inhibitor Exposure: An Example of Immune Dysregulation After Immunotherapy

Autor: Joud Arnouk, Ethan Nulton, Vikrant Rachakonda, Don Mathew

Publikováno v: ACG Case Reports Journal

Celiac disease is characterized by duodenal inflammation after exposure to gluten. Checkpoint inhibitors are antibodies that inhibit the inhibitory signals of the cytotoxic T lymphocytes to enhance antitumor responses. A 79-year-old man with an unkno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eaa5be77b9b60a3503edce423e8a611
https://doi.org/10.14309/crj.0000000000000158

A Celiac-Like Disease Phenotype After Checkpoint Inhibitor Exposure: Another of Example of Immune Dysregulation After Immunotherapy?

Autor: Don Mathew, Vikrant Rachakonda, Joud Arnouk

Publikováno v: American Journal of Gastroenterology. 113:S1426

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a51c4fa20e2fbb96c39d276e69b8f022
https://doi.org/10.14309/00000434-201810001-02563

Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score.

Autor: Marti‐Aguado, David^1,2 (AUTHOR) davidmmaa@gmail.com, Arnouk, Joud³ (AUTHOR), Liang, Jia‐Xu^4,5 (AUTHOR), Lara‐Romero, Carmen^4,5 (AUTHOR), Behari, Jaideep³ (AUTHOR), Furlan, Alessandro⁶ (AUTHOR), Jimenez‐Pastor, Ana^2,7 (AUTHOR), Ten‐Esteve, Amadeo² (AUTHOR), Alfaro‐Cervello, Clara^8,9 (AUTHOR), Bauza, Mónica¹⁰ (AUTHOR), Gallen‐Peris, Ana¹¹ (AUTHOR), Gimeno‐Torres, Marta¹² (AUTHOR), Merino‐Murgui, Víctor¹ (AUTHOR), Perez‐Girbes, Alexandre^2,13 (AUTHOR), Benlloch, Salvador^11,14 (AUTHOR), Pérez‐Rojas, Judith¹⁰ (AUTHOR), Puglia, Víctor¹⁵ (AUTHOR), Ferrández‐Izquierdo, Antonio^8,9 (AUTHOR), Aguilera, Victoria^14,16 (AUTHOR), Giesteira, Bruno¹⁷ (AUTHOR)

Publikováno v: Liver International. Jan2024, Vol. 44 Issue 1, p202-213. 12p.